ABOUT US

Engineered to Deliver What Pharma Hasn’t

VivaMed BioPharma is a clinical-stage pharmaceutical company advancing both new chemical entities and repurposed drugs in areas of urgent, unmet need—including pain, addiction, neurodegeneration, and rare diseases. We combine AI-powered development with global academic partnerships to accelerate progress, reduce risk, and bring forward therapies traditional pharma has overlooked.

WHAT SETS US APART

We’re Structured for Speed, Built for Impact

VivaMed isn’t built like traditional pharma—and that’s intentional. We’ve designed a model that identifies overlooked assets, accelerates development through AI, and leverages global partnerships to bring therapies to market faster and smarter. It’s how we reduce risk, increase success rates, and deliver meaningful change where it’s needed most.

AI-powered R&D from discovery to regulatory drafting

Expertise in both new chemical entities and repurposed drugs

50+ active assets across high-need therapeutic areas

150+ assets licensed or developed to date

39 regulatory approvals supported globally

Strategic collaborations with 30+ academic institutions

Presence in five countries across three continents

Platform model designed for faster execution and lower attrition

Partner Today

PURPOSE STATEMENT

VivaMed BioPharma strategically selects and develops compounds that address critical unmet needs in medicine. For us, return on investment isn’t the end goal—it’s a byproduct of creating meaningful impact for patients, communities, and the future of global health.

LEADERSHIP TEAM

Built by Experts. Driven by Execution.

From biotech founders to AI architects, regulatory strategists to clinical innovators—our team brings together the experience and executional power needed to change how drug development gets done.